Finance

Beta
Ask
Lists
688321:SHA
Shenzhen Chipscreen Biosciences Co Ltd
CN¥25.25
+2.64%
(+0.65) 1D
Jun 12, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688321...
Open
CN¥24.90
High
CN¥25.41
Low
CN¥24.35
Mkt. cap
10.90B
Avg. vol.
10.89M
Volume
6.76M
Dividend
0.23%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 14, 2026
P/E ratio
106.01
52-wk high
CN¥44.99
52-wk low
CN¥20.80
EPS
CN¥0.24
No. of employees
1K
Open
CN¥24.90
High
CN¥25.41
Low
CN¥24.35
Mkt. cap
10.90B
Avg. vol.
10.89M
Volume
6.76M
Dividend
0.23%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 14, 2026
P/E ratio
106.01
52-wk high
CN¥44.99
52-wk low
CN¥20.80
EPS
CN¥0.24
No. of employees
1K
News stories
From sources across the web
About Shenzhen Chipscreen Biosciences Co Ltd
CEO-
Employees1K
FoundedMar 21, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
244.33M
267.56M
235.90M
257.04M
Cost of goods sold
30.47M
31.93M
31.54M
36.50M
Cost of revenue
30.47M
31.93M
31.54M
36.50M
Research and development expenses
52.61M
56.87M
59.23M
51.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102.95M
125.30M
142.43M
125.96M
Operating expense
164.42M
183.86M
211.99M
178.42M
Total operating expenses
194.89M
215.79M
243.53M
214.92M
Operating income
49.45M
51.77M
-7.63M
42.12M
Other non operating income
117.89K
-1.49M
1.43M
-8.53M
EBT including unusual items
46.66M
42.25M
-20.26M
28.65M
EBT excluding unusual items
45.84M
45.72M
-14.06M
33.59M
Income tax expense
-2.08M
1.07M
-453.96K
380.46K
Effective tax rate
-4.47%
2.54%
2.24%
1.33%
Other operating expenses
8.46M
590.43K
8.50M
831.91K
Net income
48.75M
41.18M
-19.81M
28.27M
Net profit margin
19.95%
15.39%
-8.40%
11.00%
Earnings per share
-
-
-
-
Interest and investment income
4.45M
4.32M
3.60M
-
Interest expense
-7.63M
-9.42M
-8.76M
-
Net interest expenses
-3.18M
-5.10M
-5.16M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
66.25M
65.94M
9.31M
59.06M
Gain or loss from assets sale
10.58K
-10.58K
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more